CA3078941A1 — Low-temperature stable opioid antagonist solutions
Assigned to Emergent Biosolutions Ireland Ltd · Expires 2019-04-18 · 7y expired
What this patent protects
The present invention relates to pharmaceutical compositions comprising an opioid antagonist, PG, and an isotonicity agent. The pharmaceutical compositions are stable at temperatures as low as -5ºC or lower. Methods of using the pharmaceutical compositions are also disclosed.
USPTO Abstract
The present invention relates to pharmaceutical compositions comprising an opioid antagonist, PG, and an isotonicity agent. The pharmaceutical compositions are stable at temperatures as low as -5ºC or lower. Methods of using the pharmaceutical compositions are also disclosed.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.